Table 1.
Variable | Value |
---|---|
Age, months | 32.8 ± 0.8 |
Male, n (%) | 155 (50) |
Breastfeeding, n (%) | 11 (4) |
Stunted (HAZ < −2), % | 15.6 ± 2.4 |
Wasted (WHZ < −2), % | 1.4 ± 0.7 |
Inflammation (CRP > 5 mg/L and/or AGP > 1 g/L), % | 46.4 ± 3.1 |
Malaria, % | 8.0 ± 2.1 |
Hemoglobin, g/L | 110 ± 1 |
Anemia (Hb < 110 g/L), % | 45.4 ± 2.9 |
Severe anemia (Hb < 70 g/L), % | 1.0 ± 0.5 |
Reticulocytes, cells/µL | 47,000 ± 2000 |
Reticulocytes, cells/µL 2 | 39,000 (29,000, 54,000) 2 |
Reticulocytes > 150,000 cells/µL, n (%) | 5 (1.7) |
Unadjusted ferritin, µg/L | 51.1 ± 2.8 |
Adjusted ferritin 3, µg/L | 32.2 ± 1.2 |
Adjusted Ferritin 3 < 12 µg/L, % | 13.2 ± 2.0 |
sTfR, mg/L | 8.22 ± 0.20 |
sTfR > 8.3 mg/L, % | 25.4 ± 2.3 |
Unadjusted RBP, µmol/L | 0.88 ± 0.02 |
Adjusted RBP 3, µmol/L | 1.06 ± 0.01 |
Adjusted RBP 3 < 0.83 umol/L, % | 13.5 ± 1.9 |
Plasma zinc, µg/dL | 66.8 ± 1.6 |
Adjusted plasma zinc 3, µg/dL | 74.0 ± 1.7 |
Low adjusted plasma zinc 3,4, % | 23.2 ± 3.8 |
Folate, nmol/L | 56.0 ± 2.1 |
Plasma B12, pmol/L | 851 ± 51 |
1 Values are mean or % ± SE or n (%), unless otherwise indicated; n = 278–302, depending on the indicator. AGP, alpha-1-acid glycoprotein; CRP, C-reactive protein; HAZ, height-for-age Z-score; Hb, hemoglobin; sTfR, soluble transferrin receptor, WAZ, weight-for-age Z-score; WHZ, weight-for-height Z-score. 2 Median (25th percentile, 75th percentile). 3 Values adjusted for inflammation by regression analysis to values equivalent to those at CRP and AGP concentrations of 0.14 mg/L CRP and 0.52 g/L AGP (the 10th percentile among individuals with CRP < 5 and AGP < 1). 4 Low plasma zinc defined as <65 µg/dL for morning samples and <57 µg/dL for afternoon samples [23], after adjusting for inflammation as noted above.